News & Insights
All News & Insights
Biofourmis names new CFO to help drive the digital medicine start-up's growth plans
Biofourmis names new CFO to help drive the digital medicine start-up's growth plans
Biofourmis names new CFO, Matt Borowiecki to help drive the digital medicine start-up’s growth plans.
Digital Medicine Leader Biofourmis Expands into Oncology Market with Strategic Acquisition of Gaido Health
Digital Medicine Leader Biofourmis Expands into Oncology Market with Strategic Acquisition of Gaido Health
Our digital medicine company announced it has finalized an agreement to acquire Gaido Health from Takeda Pharmaceuticals expanding our portfolio into Oncology.
Biofourmis' AI-Powered Remote Monitoring Platform to Provide New Insights to Fight COVID-19 in Disease Monitoring Program in Hong Kong
Biofourmis' AI-Powered Remote Monitoring Platform to Provide New Insights to Fight COVID-19 in Disease Monitoring Program in Hong Kong
Biofourmis' AI-Powered Remote Monitoring Platform will remotely monitor COVID-19 cases and apply personalized predictive analytics to help patients.
Biofourmis Partners with ImagineMIC to Pioneer Collaborative Remote Patient Monitoring Model
Biofourmis Partners with ImagineMIC to Pioneer Collaborative Remote Patient Monitoring Model
Biofourmis and Imagine MIC announce a partnership agreement on a collaborative patient monitoring model to lower health costs for patients with chronic diseases.
Biofourmis Names Pharma and Tech Veterans as COO and CTO
Biofourmis Names Pharma and Tech Veterans as COO and CTO
Biofourmis, a leader in virtual care delivery and digital medicine, have named Pharma and Tech Veterans Jaydev Thakkar and Milan Shah as COO and CTO.
Biofourmis Forms Alliance With Global Healthcare Company To Offer Digital Medicine For Patients With Heart Failure
Biofourmis Forms Alliance With Global Healthcare Company To Offer Digital Medicine For Patients With Heart Failure
Our remote healthcare company forms an alliance with global healthcare company to offer digital medicine for patients with heart failure.
Biofourmis Announces Acquisition of Biovotion AG, Completing Biovitals® Platform to Deliver Precise Interventions at the Right Time to Manage Patients with Complex Chronic Conditions
Biofourmis Announces Acquisition of Biovotion AG, Completing Biovitals® Platform to Deliver Precise Interventions at the Right Time to Manage Patients with Complex Chronic Conditions
Acquisition of Biovotion establishes Biovitals® as the most comprehensive predictive digital medicine solution for healthcare providers, payers and pharmaceutical companies.
Biofourmis' Biovitals™ Analytics Engine Receives FDA Clearance for Ambulatory Physiologic Monitoring
Biofourmis' Biovitals™ Analytics Engine Receives FDA Clearance for Ambulatory Physiologic Monitoring
The approval of the Biovitals™ Analytics Engine is part of FDA’s growing recognition of machine-learning and AI in the Software as a Medical Device category.
Biofourmis Named to the 2019 CB Insights Digital Health 150 List of Most Innovative Digital Health Startups
Biofourmis Named to the 2019 CB Insights Digital Health 150 List of Most Innovative Digital Health Startups
Our remote healthcare company was included in the 2019 CB insights digital health 150 list of most innovative digital health startups.